Clinical Trial Update: Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing treatment of non-alcoholic fatty liver disease with n-3 fatty acids completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• N-3 Fatty Acids (omega-3 fatty acids)

Snippet

Sponsor: University Hospital Southampton NHS Foundation Trust | Conditions: Non-Alcoholic Fatty Liver Disease | Phase 4 | Status: COMPLETED | Results posted: 2019-10-25